BG61683B1 - Получаване и използване на убити с формалин организми от видае. coli, експресиращи антиген на колонийобразуващия фактор, заваксиниране срещу чревни инфекции/диарии, причинени отентеротоксични бактерии на e. coli у хората - Google Patents
Получаване и използване на убити с формалин организми от видае. coli, експресиращи антиген на колонийобразуващия фактор, заваксиниране срещу чревни инфекции/диарии, причинени отентеротоксични бактерии на e. coli у хората Download PDFInfo
- Publication number
- BG61683B1 BG61683B1 BG98070A BG9807093A BG61683B1 BG 61683 B1 BG61683 B1 BG 61683B1 BG 98070 A BG98070 A BG 98070A BG 9807093 A BG9807093 A BG 9807093A BG 61683 B1 BG61683 B1 BG 61683B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- cfa
- coli
- bacteria
- formalin
- colony
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/848—Escherichia
- Y10S435/849—Escherichia coli
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9100556A SE9100556D0 (sv) | 1991-02-26 | 1991-02-26 | Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans |
| PCT/SE1992/000110 WO1992014487A1 (fr) | 1991-02-26 | 1992-02-25 | Preparation et utilisation d'organismes de e. coli tues dans le formol et exprimant un antigene de facteur de colonisation (cfa) dans le but d'une vaccination contre les infections enteriques et/ou diarrhees provoquees par des bacteries de e. coli enterotoxicogenes chez l'homme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG98070A BG98070A (bg) | 1994-06-30 |
| BG61683B1 true BG61683B1 (bg) | 1998-03-31 |
Family
ID=20381987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG98070A BG61683B1 (bg) | 1991-02-26 | 1993-08-25 | Получаване и използване на убити с формалин организми от видае. coli, експресиращи антиген на колонийобразуващия фактор, заваксиниране срещу чревни инфекции/диарии, причинени отентеротоксични бактерии на e. coli у хората |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6558678B1 (fr) |
| EP (1) | EP0573527B1 (fr) |
| JP (1) | JP3169608B2 (fr) |
| KR (1) | KR100221452B1 (fr) |
| AT (1) | ATE170755T1 (fr) |
| AU (1) | AU663864B2 (fr) |
| BG (1) | BG61683B1 (fr) |
| BR (1) | BR9205677A (fr) |
| CA (1) | CA2104877C (fr) |
| CZ (1) | CZ281556B6 (fr) |
| DE (1) | DE69226944T2 (fr) |
| DK (1) | DK0573527T3 (fr) |
| ES (1) | ES2123550T3 (fr) |
| FI (1) | FI108775B (fr) |
| HU (1) | HU213924B (fr) |
| NO (1) | NO307867B1 (fr) |
| OA (1) | OA09865A (fr) |
| RO (1) | RO109819B1 (fr) |
| RU (1) | RU2127121C1 (fr) |
| SE (1) | SE9100556D0 (fr) |
| SK (1) | SK280919B6 (fr) |
| WO (1) | WO1992014487A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7118758B1 (en) * | 1997-01-24 | 2006-10-10 | The United States Of America As Represented By The Secretary Of The Army | Transformed bacteria producing CS6 antigens as vaccines |
| SE9401921D0 (sv) * | 1994-06-03 | 1994-06-03 | Sbl Vaccin Ab | A method of cultivating bacteria |
| US7094883B1 (en) | 1996-08-02 | 2006-08-22 | The United States Of America As Represented By The Secretary Of The Army | Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein |
| US7404961B2 (en) | 1996-08-02 | 2008-07-29 | The United States Of America As Represented By The Secretary Of The Army | Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins |
| US5994078A (en) * | 1997-07-31 | 1999-11-30 | Maine Medical Center | Stable encapsulated reference nucleic acid and method of making |
| SE515285C2 (sv) * | 1998-12-18 | 2001-07-09 | Sbl Vaccin Ab | Oralt vaccin mot diarré |
| GB0121998D0 (en) * | 2001-09-11 | 2001-10-31 | Acambis Res Ltd | Attenuated bacteria useful in vaccines |
| JP5100122B2 (ja) * | 2003-10-31 | 2012-12-19 | ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア | 細菌の病原因子とそれらの使用 |
| EP1981536A4 (fr) * | 2006-02-01 | 2012-03-14 | Gotovax Ab | Antigenes de facteur de colonisation d'escherichia coli enterotoxigenes dans des bacteries recombinees |
| BR112013027845A2 (pt) * | 2011-05-18 | 2017-01-03 | Ajinomoto Kk | Imunoestimulante, ração, método para produzir um imunoestimulante, e, método para imunoestimulação |
| US8926980B2 (en) | 2011-07-11 | 2015-01-06 | Camas Incorporated | Compositions against bacterial toxins |
| DK2750701T3 (en) * | 2011-09-12 | 2016-01-11 | Scandinavian Biopharma Holding Ab | PROCEDURE FOR INCREASING ETEC-CS6 ANTIGEN PRESENTATION ON CELL SURFACE AND THEREFORE AVAILABLE PRODUCTS |
| BR112014005601B1 (pt) | 2011-09-12 | 2020-09-29 | Scandinavian Biopharma Holding Ab | Vacina oral para a imunização contra a diarréia induzida pela etec |
| RO132299A3 (ro) | 2017-06-06 | 2018-12-28 | Fântână Raul Sorin | Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active () |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD62894A (fr) * | ||||
| DE1208038B (de) * | 1963-08-01 | 1965-12-30 | Wellcome Found | Verfahren zur Herstellung von Impfstoffen gegen Coli-Infektionen |
| GB1472624A (en) * | 1974-09-02 | 1977-05-04 | Canadian Patents Dev | Enteric disease vaccine |
| US4338298A (en) * | 1980-04-04 | 1982-07-06 | Endowment And Research Foundation At Montana State University | Vaccine for passive immunization against enteric colibacillosis and method of use |
| DK41885A (da) * | 1985-01-31 | 1986-11-13 | Slagteriernes Forskningsinst | 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen |
| DE3650065T2 (de) * | 1985-07-31 | 1995-03-02 | Univ Leland Stanford Junior | Invasive Mikroorganismen. |
| FI76484C (fi) | 1986-02-03 | 1988-11-10 | Osmo Norvasto | Kundstol. |
| JPS6399020A (ja) * | 1986-06-05 | 1988-04-30 | ベイラ− カレツジ オブ メデイシン | ワクチンとその製法 |
| SU1723116A1 (ru) * | 1988-04-15 | 1992-03-30 | Оренбургский Государственный Медицинский Институт | Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний |
| DE68929405T2 (de) * | 1988-09-06 | 2003-02-06 | Washington University, St. Louis | Orale-immunisierung durch verwendung von transgenen pflanzen |
| SE9401921D0 (sv) * | 1994-06-03 | 1994-06-03 | Sbl Vaccin Ab | A method of cultivating bacteria |
-
1991
- 1991-02-26 SE SE9100556A patent/SE9100556D0/xx unknown
-
1992
- 1992-02-25 SK SK910-93A patent/SK280919B6/sk unknown
- 1992-02-25 AU AU13308/92A patent/AU663864B2/en not_active Ceased
- 1992-02-25 CA CA002104877A patent/CA2104877C/fr not_active Expired - Fee Related
- 1992-02-25 ES ES92906078T patent/ES2123550T3/es not_active Expired - Lifetime
- 1992-02-25 DE DE69226944T patent/DE69226944T2/de not_active Expired - Fee Related
- 1992-02-25 AT AT92906078T patent/ATE170755T1/de not_active IP Right Cessation
- 1992-02-25 EP EP92906078A patent/EP0573527B1/fr not_active Expired - Lifetime
- 1992-02-25 RO RO93-01142A patent/RO109819B1/ro unknown
- 1992-02-25 CZ CS931742A patent/CZ281556B6/cs not_active IP Right Cessation
- 1992-02-25 RU RU93053899A patent/RU2127121C1/ru not_active IP Right Cessation
- 1992-02-25 JP JP50610592A patent/JP3169608B2/ja not_active Expired - Fee Related
- 1992-02-25 WO PCT/SE1992/000110 patent/WO1992014487A1/fr active IP Right Grant
- 1992-02-25 KR KR1019930702564A patent/KR100221452B1/ko not_active IP Right Cessation
- 1992-02-25 HU HU9302410A patent/HU213924B/hu not_active IP Right Cessation
- 1992-02-25 DK DK92906078T patent/DK0573527T3/da active
- 1992-02-25 US US08/108,606 patent/US6558678B1/en not_active Expired - Fee Related
- 1992-02-25 BR BR9205677A patent/BR9205677A/pt not_active Application Discontinuation
-
1993
- 1993-08-24 OA OA60404A patent/OA09865A/en unknown
- 1993-08-25 FI FI933728A patent/FI108775B/fi active
- 1993-08-25 NO NO933037A patent/NO307867B1/no unknown
- 1993-08-25 BG BG98070A patent/BG61683B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Holmgren et al. | Mechanisms of disease and immunity in cholera: a review | |
| Black et al. | Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin | |
| CA2198586C (fr) | Enterotoxine mutante efficace comme adjuvant oral non toxique | |
| Evans et al. | Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers: response to challenge with virulent enterotoxigenic Escherichia coli | |
| BG61683B1 (bg) | Получаване и използване на убити с формалин организми от видае. coli, експресиращи антиген на колонийобразуващия фактор, заваксиниране срещу чревни инфекции/диарии, причинени отентеротоксични бактерии на e. coli у хората | |
| Holmgren et al. | Cross‐reactivity between heat labile enterotoxins of Vibrio cholerae and Escherichia coli in neutralization tests in rabbit ileum and skin | |
| Sizemore et al. | Enterotoxigenic Escherichia coli virulence factors and vaccine approaches | |
| Richardson | Animal models in cholera research | |
| Lasaro et al. | Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli | |
| Svennerholm et al. | Immunity to Vibrio cholerae infection | |
| AU774649B2 (en) | Vaccine preparations containing attenuated toxin | |
| AU778223B2 (en) | Oral vaccine against diarrhea | |
| RU2130970C1 (ru) | Культура v.cholerae, способ получения делеционных мутантов | |
| US4728639A (en) | Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant | |
| Boesman-Finkelstein et al. | Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine | |
| Carlin et al. | Oral vaccines for enterotoxigenic Escherichia coli | |
| Beachey | Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant | |
| Gilligan et al. | Oral enteric vaccines—clinical trials | |
| Rijpkema et al. | Immunoglobulins in bile and serum of the rabbit associated with protection after Vibrio cholerae infection and vaccination | |
| Aron et al. | Humoral immune response to Salmonella typhi outer membrane proteins | |
| Corthésy et al. | Transcutaneous Immunization Using |